「no」の検索結果
160件：21～25件目を表示
-
千寿製薬株式会社
obtained approval for a BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distrib...
http://www.senju.co.jp/english/ -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
We contribute to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the en
https://www.senju.co.jp/english/about/csr.html -
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
Wellness items that promote health every day to contribute to the health of all people. Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drug
https://www.senju.co.jp/english/about/business/ec.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
http://www.senju.co.jp/english/rd/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
crine deactivation activity Khanh Tien Nguyen Pham 1, Takahito Miyake 1, Tomo Suzuki 2,3, Shigeru Kinoshita4, Yuki Hamada 1, Hikari Uehara 1, Mamiko Machida 5, Takeshi Nakajima 5, Emi Hasegawa1, and M...
https://www.senju.co.jp/rd/thesis/